Latest filing published 09 Mar 2023 for Aquestive Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +16.3%Entry US$7.55 · Close at T+365 US$8.78
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ken W. Marshall: trading record in brief
Ken W. Marshall appears in our data through filings on Aquestive Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 21 November 2018 and the latest from 9 March 2023.
Purchases make up the whole of the open-market record (1 purchase, €13k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant.
Most recently, on 9 March 2023, the filings show a share grant in Aquestive Therapeutics, Inc. The most recent open-market purchase was published on 3 December 2018, 2,898 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ken W. Marshall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares0Common StockSEC:0001214659-23-003694:0
- 1,445 shares@ US$10.15100.0% of flowCommon StockSEC:0001140361-18-044399:0Canonical exit: 19 Feb 2019 (T+90)
2 of 2 declarations